Prof. Dr. Falk Nimmerjahn

Lehrstuhl für Genetik

IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM). (2017) Wege AK, Weber F, Kroemer A, Ortmann O, Nimmerjahn F, Brockhoff G Journal article Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response (2017) Lehmann B, Biburger M, Brückner C, Ipsen Escobedo A, Gordan S, Lehmann C, Vöhringer D, et al. Journal article, Original article Comparative analysis of human dendritic cell subpopulations in steady state and inflammation (2017) Heger L, Heidkamp GF, Lehmann C, Eissing N, Söder S, Hartmann A, Zenk J, et al. Conference contribution Antigen targeting of Fc-receptors induces strong T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subset (2017) Lehmann CHK, Baranska A, Heidkamp GF, Heger L, Neubert K, Lühr J, Hoffmann A, et al. Conference contribution Antigen targeting of Fc-receptors induces strong T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subsets (2017) Lehmann C, Baranska A, Heidkamp GF, Heger L, Neubert K, Lühr J, Hoffmann A, et al. Conference contribution Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2017) Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, Lühr J, et al. Conference contribution The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies (2017) Lehmann C, Heger L, Neubert K, Harzer C, Amon L, Yamazaki S, Heidkamp GF, et al. Conference contribution Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation (2017) Brückner C, Lehmann C, Dudziak D, Nimmerjahn F Journal article IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice (2017) Kao D, Lux A, Schaffert A, Lang R, Altmann F, Nimmerjahn F Journal article Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. (2016) Ortiz DF, Lansing JC, Rutitzky L, Kurtagic E, Prod'Homme T, Choudhury A, Washburn N, et al. Journal article